Please find enclosed herewith outcome of the meeting for your reference.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.7 pts less than Nifty Microcap 250 and 11.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Royal Sense Ltd's Board, at its meeting on November 13, 2025, approved unaudited standalone and consolidated financial results for the half-year ended September 30, 2025, along with a Limited Review Report from CND & Associates (unmodified opinion). On a standalone basis, revenue from operations rose to ₹2,075.76 lakhs in H1 FY26, up about 25% from ₹1,657.01 lakhs in H1 FY25. Standalone profit after tax jumped to ₹195.31 lakhs (from ₹111.93 lakhs), with basic EPS of ₹3.65 versus ₹2.28. On a consolidated basis, revenue from operations was ₹4,348.34 lakhs with profit after tax of ₹405.60 lakhs and basic EPS of ₹7.58, reflecting contributions from its wholly-owned subsidiary Stergic Retail Private Limited. The auditor also confirmed full utilization of ₹679.50 lakhs raised via the preferential issue (₹509.63L for working capital and ₹169.87L for general corporate purposes). However, operating cash flow was negative on both standalone (-₹16.66L) and consolidated (-₹1,299.15L) bases, mainly due to a sharp jump in trade receivables.
Strong top-line and bottom-line growth on a year-on-year basis is a positive signal for shareholders, though the negative operating cash flow and ballooning trade receivables are watchpoints that could pressure short-term liquidity.